www.dailypolitical.com ·
Christopher Horan Sells 7002 Shares of Artiva Biotherapeutics Nasdaqartv Stock
Topic context
This topic has been covered 311405 times in the last 7 days across our monitored publishers.
The full article is on the original publisher site.
AI insight
AI-generatedInsider stock sale for tax withholding is a routine non-discretionary transaction with no direct commercial mechanism. The company is a clinical-stage biotech with a wider-than-expected quarterly loss, but no product revenue, supply chain, or margin channel is affected. Sector PHARMA_BIOTECH is included only because the company operates in that sector; no concrete commercial signal. (not specified)
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Insider Christopher Horan sold 7,002 shares of Artiva Biotherapeutics (NASDAQ:ARTV) on May 19, 2026 at $9.01 per share.
- The sale was to cover tax withholding obligations related to equity awards.
- Artiva reported a quarterly loss of $0.95 per share, wider than analyst expectations.
- Stock twelve-month range: $1.47 to $14.53; market cap $193.80 million.
Related stories
baomoi.com
Ra Soat Lich Su Tiem Chung Doi Voi Hoc Sinh Tieu Hoc Tu 1 7
freemalaysiatoday.com
Stocks Rally While Oil and Dollar Ease on Middle East Peace Hopes
bazonline.ch
Ticker USA Donald Trump Whashington Elections 3
actionforex.com
641585 us futures gap up on us iran peace deal hopes with us dollar in retreat
globalsecurity.org